Arvinas (ARVN) Non Operating Income (2017 - 2026)

Arvinas (ARVN) recorded quarterly Non Operating Income of $6.3 million in Q1 2026, down 83.59% quarter-over-quarter from $38.4 million in Q4 2025, and down 46.15% on a YoY basis from $11.7 million in Q1 2025.

Arvinas (ARVN) Non Operating Income (2017 - 2026) Analysis & Trends

Arvinas' Non Operating Income history runs 10 years deep, the most recent figure standing at $6.3 million for Q1 2026.

  • In Q1 2026, Non Operating Income fell 46.15% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $53.4 million (up 373.85% YoY), while the FY2025 annual figure was $38.0 million, up 1410.34% from the prior year.
  • Non Operating Income was $6.3 million for Q1 2026 at Arvinas, down from $38.4 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $38.4 million in Q4 2025 to a low of -$42.1 million in Q4 2024.
  • Historically, Non Operating Income has averaged $2.6 million across 5 years, with a median of $4.0 million in 2022.
  • Biggest YoY gain for Non Operating Income was 5100.0% in 2023; the steepest drop was 4550.0% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $600000.0 in 2022, then slumped by 4550.0% to -$26.7 million in 2023, then tumbled by 57.68% to -$42.1 million in 2024, then jumped by 191.21% to $38.4 million in 2025, then sank by 83.59% to $6.3 million in 2026.
  • The last three Non Operating Income figures came in at $6.3 million (Q1 2026), $38.4 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 6.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.30 Mn
Dec 31, 2025 38.40 Mn
Sep 30, 2025 9.00 Mn
Jun 30, 2025 -300,000.00
Mar 31, 2025 11.70 Mn
Dec 31, 2024 -42.10 Mn
Sep 30, 2024 -2.60 Mn
Jun 30, 2024 13.50 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 -26.70 Mn
Sep 30, 2023 10.00 Mn
Mar 31, 2023 6.50 Mn
Dec 31, 2022 600,000.00
Sep 30, 2022 -200,000.00
Jun 30, 2022 1.70 Mn
Mar 31, 2022 1.10 Mn
Dec 31, 2021 800,000.00
Sep 30, 2021 500,000.00
Jun 30, 2021 1.60 Mn
Mar 31, 2021 200,000.00